Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBIG for Cure in Chronic Hepatitis B
NCT05345990Phase 2Terminated
- Sponsor
- Hannover Medical School
- Start
- Aug 2022
- Primary completion
- Jul 2025
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of hepatitis B immune globulin in Chronic Hepatitis B (CHB), sponsored by Hannover Medical School. Started Aug 2022; status: terminated.
02
Drugs
hepatitis B immune globulin
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT05345990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05345990.